Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tetratricopeptide repeat domain 1 (TTC1) is a protein that features tetratricopeptide repeats (TPR), which are structural motifs that mediate protein–protein interactions[1][3][5]. TTC1 functions prominently as an adaptor protein bridging the signaling between heterotrimeric G protein subunits and the small GTPase Ras, directly interacting with multiple Galpha subunits and preferentially binding to the active, GTP-bound form of Ras[1]. This adaptor role facilitates signal transduction from G protein-coupled receptors to downstream Ras-dependent mitogenic pathways such as ERK and IκB kinase activation. In addition to serving as a signaling scaffold, TTC1 also acts as a chaperone adaptor, promoting protein folding in synergy with chaperones like Hsp70 and Hsp40[1]. While TPR domain-containing proteins are implicated in a variety of cellular processes—including cell cycle regulation, transcriptional control, and mitochondrial function—TTC1 itself is chiefly recognized for its roles in maintaining proteostasis and regulating Ras signaling cascades[1][6]. TTC1 is a protein-coding gene (human gene symbol: TTC1, NCBI Gene ID: 7265), with mutations or dysregulation associated with conditions such as Seckel syndrome and inflammatory bowel disease[7]. No approved therapeutic drugs, mechanisms of action, or established biomarkers relating to TTC1 have been reported in current sources.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tetratricopeptide repeat domain 1 (TTC1).